Wave Life Sciences Reports Q3 Revenue Beat and Improved Earnings Per Share
Wave Life Sciences (WVE) reported third-quarter financial results that exceeded analyst expectations for both revenue and earnings per share. The company posted GAAP EPS of -$0.30, a $0.03 beat, while revenue reached $13.16 million, representing a 72.9% increase year-over-year and surpassing estimates by $8.77 million. The biotechnology firm maintains a strong liquidity position with $431 million in cash, cash equivalents, and marketable securities as of September 30, 2026. Additionally, the company expects to receive an extra $12 million milestone payment from GSK, further bolstering its capital reserves for ongoing operations.
Topics: cash position earnings beat milestone payments revenue growth
Read the full article at Seeking Alpha
Part of the story Reddit Shares Plunge 29% Following Weak Earnings and Declining Search Traffic (31 articles)